Form 4: Vertex Pharmaceuticals EVP Charles Wagner Jr. Reports Stock Disposal
SEC Form 4 Filing
Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals, reported disposing of 3,309 shares of common stock on February 23, 2024, to cover tax obligations.
Summary
- On February 23, 2024, Charles F. Wagner Jr., the EVP & Chief Financial Officer of Vertex Pharmaceuticals, disposed of 3,309 shares of common stock.
- The transaction was executed at a price of $431.79 per share.
- Following the transaction, Wagner directly owns 53,583 shares of Vertex Pharmaceuticals.
- The disposal was related to covering tax obligations.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a stock disposal, likely to cover tax obligations, which is a routine transaction.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's stock.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine disposal of shares by an executive for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Date of stock disposal transaction |
| 02/27/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.